Single User License
INR 101340
Site License
INR 202680
Corporate User License
INR 304020

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


CrystalGenomics, Inc.-Product Pipeline Review-2016

CrystalGenomics, Inc.-Product Pipeline Review-2016


  Request for Sample Report

Executive Summary

CrystalGenomics, Inc.-Product Pipeline Review-2016

Summary

Global Markets Direct's, 'CrystalGenomics, Inc.-Product Pipeline Review, 2016', provides an overview of the CrystalGenomics, Inc.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by CrystalGenomics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of CrystalGenomics, Inc.

The report provides overview of CrystalGenomics, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses CrystalGenomics, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features CrystalGenomics, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

Evaluate CrystalGenomics, Inc.'s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for CrystalGenomics, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding CrystalGenomics, Inc.'s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

CrystalGenomics, Inc. Snapshot 5

CrystalGenomics, Inc. Overview 5

Key Information 5

Key Facts 5

CrystalGenomics, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

CrystalGenomics, Inc.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

CrystalGenomics, Inc.-Pipeline Products Glance 12

CrystalGenomics, Inc.-Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

CrystalGenomics, Inc.-Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

CrystalGenomics, Inc.-Drug Profiles 16

CG-400549 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

CG-200745 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

CG-026806 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

CG-036806 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

polmacoxib 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

CG-0009 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Small Molecule to Target Metalloproteinases for Undisclosed Indication 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Small Molecule to Target Nuclear Hormone Receptors for Undisclosed Indication 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Small Molecule to Target Phosphodiesterases for Undisclosed Indication 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

CrystalGenomics, Inc.-Pipeline Analysis 26

CrystalGenomics, Inc.-Pipeline Products by Target 26

CrystalGenomics, Inc.-Pipeline Products by Route of Administration 28

CrystalGenomics, Inc.-Pipeline Products by Molecule Type 29

CrystalGenomics, Inc.-Pipeline Products by Mechanism of Action 30

CrystalGenomics, Inc.-Recent Pipeline Updates 31

CrystalGenomics, Inc.-Dormant Projects 34

CrystalGenomics, Inc.-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Appendix 36

Methodology 36

Coverage 36

Secondary Research 36

Primary Research 36

Expert Panel Validation 36

Contact Us 36

Disclaimer 37

List of Figures

CrystalGenomics, Inc.-Pipeline by Top 10 Indication, 2016 7

CrystalGenomics, Inc.-Pipeline by Stage of Development, 2016 8

CrystalGenomics, Inc.-Monotherapy Products in Pipeline, 2016 9

CrystalGenomics, Inc.-Pipeline by Target, 2016 26

CrystalGenomics, Inc.-Pipeline by Route of Administration, 2016 28

CrystalGenomics, Inc.-Pipeline by Molecule Type, 2016 29

CrystalGenomics, Inc.-Pipeline Products by Mechanism of Action, 2016 30

List of Tables

CrystalGenomics, Inc., Key Information 5

CrystalGenomics, Inc., Key Facts 5

CrystalGenomics, Inc.-Pipeline by Indication, 2016 7

CrystalGenomics, Inc.-Pipeline by Stage of Development, 2016 8

CrystalGenomics, Inc.-Monotherapy Products in Pipeline, 2016 9

CrystalGenomics, Inc.-Partnered Products in Pipeline, 2016 10

CrystalGenomics, Inc.-Partnered Products/ Combination Treatment Modalities, 2016 11

CrystalGenomics, Inc.-Phase II, 2016 12

CrystalGenomics, Inc.-Phase I, 2016 13

CrystalGenomics, Inc.-Preclinical, 2016 14

CrystalGenomics, Inc.-Discovery, 2016 15

CrystalGenomics, Inc.-Pipeline by Target, 2016 27

CrystalGenomics, Inc.-Pipeline by Route of Administration, 2016 28

CrystalGenomics, Inc.-Pipeline by Molecule Type, 2016 29

CrystalGenomics, Inc.-Pipeline Products by Mechanism of Action, 2016 30

CrystalGenomics, Inc.-Recent Pipeline Updates, 2016 31

CrystalGenomics, Inc.-Dormant Developmental Projects,2016 34

CrystalGenomics, Inc., Subsidiaries 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of CrystalGenomics, Inc.; CrystalGenomics, Inc.-Key Therapeutics; CrystalGenomics, Inc.-Pipeline Overview and Promising Molecules; CrystalGenomics, Inc.-News; CrystalGenomics, Inc.-Latest Updates; CrystalGenomics, Inc.-Pipeline; CrystalGenomics, Inc.-Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com